Literature DB >> 23604759

Metabolism and toxicokinetics of the mycotoxin ochratoxin A in F344 rats.

H Zepnik1, W Völkel, W Dekant.   

Abstract

Male (n=18) and female (n=18) F344 rats were administered a single dose of OTA (0.5 mg/kg b.w.) in corn oil by gavage. Animals (n=3) were sacrificed 24, 48, 72, 96, 672 and 1,344 hours after OTA administration and concentrations of OTA and OTA-metabolites in urine, feces, blood, liver and kidney were determined by HPLC with fluorescence detection and/or by LC-MS/MS. Recovery of unchanged OTA in urine amounted to 2.1% of dose in males and 5.2% in females within 96 h. In feces, only 5.5% resp. 1.5% of dose were recovered. The major metabolite detected was OTalpha, low concentrations of OTA-glucosides were also present in urine. Other postulated metabolites were not observed. The maximal blood levels of OTA were observed between 24 and 48h after administration and were app. 4.6 µmol/l in males and 6.0 µmol/l in females. Elimination of OTA from blood followed first-order kinetics with a half-life of app. 230h calculated from 48h to 1344h. In liver of both male and female rats OTA-concentrations were less than 12 pmol/g tissue, with a maximum at 24h after administration. In contrast, OTA accumulated in the kidneys, reaching a concentration of 480 pmol/g tissue in males 24h after OTA-administration. In general, tissue concentrations in males were higher than in females. OTalpha was not detected in liver and kidney tissue of rats administered OTA and OTalpha concentrations in blood were low (10-15 nmol/1). The high concentrations of OTA in kidneys of male rats may explain the organ- and gender-specific toxicity of OTA.

Entities:  

Year:  2003        PMID: 23604759     DOI: 10.1007/BF02942946

Source DB:  PubMed          Journal:  Mycotoxin Res        ISSN: 0178-7888            Impact factor:   3.833


  15 in total

1.  Detection and characterization of a glutathione conjugate of ochratoxin A.

Authors:  Jian Dai; Gyungse Park; Marcus W Wright; Marissa Adams; Steven A Akman; Richard A Manderville
Journal:  Chem Res Toxicol       Date:  2002-12       Impact factor: 3.739

2.  Toxicokinetics of ochratoxin A in several species and its plasma-binding properties.

Authors:  S Hagelberg; K Hult; R Fuchs
Journal:  J Appl Toxicol       Date:  1989-04       Impact factor: 3.446

3.  Ochratoxin A-induced tumor formation: is there a role of reactive ochratoxin A metabolites?

Authors:  H Zepnik; A Pähler; U Schauer; W Dekant
Journal:  Toxicol Sci       Date:  2001-01       Impact factor: 4.849

4.  Identification of ochratoxins and some of their metabolites in bile and urine of rats.

Authors:  S Li; R R Marquardt; A A Frohlich
Journal:  Food Chem Toxicol       Date:  2000 Feb-Mar       Impact factor: 6.023

Review 5.  Ochratoxin A in blood and its pharmacokinetic properties.

Authors:  R Fuchs; K Hult
Journal:  Food Chem Toxicol       Date:  1992-03       Impact factor: 6.023

6.  Ochratoxin A-related DNA adducts in urinary tract tumours of Bulgarian subjects.

Authors:  A Pfohl-Leszkowicz; Y Grosse; M Castegnaro; I G Nicolov; I N Chernozemsky; H Bartsch; A M Betbeder; E E Creppy; G Dirheimer
Journal:  IARC Sci Publ       Date:  1993

7.  Metabolism of ochratoxin A by rats.

Authors:  O Støren; H Holm; F C Størmer
Journal:  Appl Environ Microbiol       Date:  1982-10       Impact factor: 4.792

8.  Toxicology and Carcinogenesis Studies of Ochratoxin A (CAS No. 303-47-9) in F344/N Rats (Gavage Studies).

Authors: 
Journal:  Natl Toxicol Program Tech Rep Ser       Date:  1989-05

9.  Metabolic fate of indeloxazine hydrochloride: alpha-glucoside formation in rats.

Authors:  H Kamimura; R Kawai; H Kudo
Journal:  Xenobiotica       Date:  1988-02       Impact factor: 1.908

Review 10.  The etiology of Balkan endemic nephropathy: still more questions than answers.

Authors:  C A Tatu; W H Orem; R B Finkelman; G L Feder
Journal:  Environ Health Perspect       Date:  1998-11       Impact factor: 9.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.